Real-time enrollment status for this congenital adrenal hyperplasia clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 5:46 PM UTC
| NCT Number | NCT06712823 |
| Recruiting Status | Recruiting |
| Condition | Congenital Adrenal Hyperplasia |
| Phase | PHASE2 |
| Target Enrollment | 200 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Crinetics Pharmaceuticals Inc. |
| Last Updated on CT.gov | June 29, 2026 (2 weeks ago) |
As of July 18, 2026: Clinical trial NCT06712823 is currently recruiting participants. This phase2 study for congenital adrenal hyperplasia is actively seeking new participants at 3 locations across the United States. The study is sponsored by Crinetics Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06712823 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06712823 was last updated 2 weeks ago (June 29, 2026). HelloStudys verifies this status automatically.